Jingyu Yu
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- HER2/EGFR in Cancer Research 3
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 3
- Immunology top 10%
-
- Pharmaceutical studies and practices 4
-
- Pharmacogenetics and Drug Metabolism 3
-
- CRISPR and Genetic Engineering 3
- Extracellular vesicles in disease 2
- Co-authors
- Richard PazdurGideon M. BlumenthalPatricia KeeganKirsten B. GoldbergHong ZhaoKun HeSriram SubramaniamAmy E. McKee
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Jingyu Yu
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Oncology 871
- Pulmonary and Respiratory Medicine 439
- Immunology 224
- Cancer Research 143
- Radiology, Nuclear Medicine and Imaging 177
Countries citing papers authored by Jingyu Yu
This map shows the geographic impact of Jingyu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyu Yu more than expected).
Fields of papers citing papers by Jingyu Yu
This network shows the impact of papers produced by Jingyu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyu Yu. The network helps show where Jingyu Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 28 | |
| 7 | 2022 | 29 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 118 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 135 | |
| 13 | Treatment of Chronic Nonbacterial Prostatitis Majorly with Deep Acupuncture at Baliao Points plus Western Medication: A Randomized Controlled Study | 2019 | 1 |
| 14 | 2019 | 3 | |
| 15 | 2018 | 24 | |
| 16 | 2018 | 88 | |
| 17 | 2018 | 75 | |
| 18 | 2017 | 228 | |
| 19 | 2017 | 172 | |
| 20 | 2017 | 115 |
About Jingyu Yu
Jingyu Yu is a scholar working on Oncology, Pharmacology and Statistics and Probability, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Pharmaceutical studies and practices (4 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), CRISPR and Genetic Engineering (3 papers), HER2/EGFR in Cancer Research (3 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Oncology (871 citations), Pulmonary and Respiratory Medicine (439 citations) and Immunology (224 citations). Jingyu Yu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Richard Pazdur, Gideon M. Blumenthal, Patricia Keegan, Kirsten B. Goldberg, Hong Zhao, Kun He, Sriram Subramaniam, Amy E. McKee, Hongshan Li and Mark Paciga. Their work appears in journals such as PLoS ONE, Brain and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.